Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of PTEN-null, BRAFV600E melanoma to BRAF/MEK inhibitionEvan S. Dubose, Steven P. Angus|Frontiers in Oncology|2024Cited by 7